Plain-English translation of NCT07196657 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer medication called works better than , a medicine currently used to treat fibromyalgia. Fibromyalgia is a chronic condition that causes widespread pain, tiredness, and mood problems. The study wants to find out if the new treatment might offer better pain relief with fewer side effects.
Current fibromyalgia medications like only help about 25–40% of patients manage their pain, and many people experience unwanted side effects. This trial exists to see whether this newer medication could be a better option for people who aren't getting enough relief from existing treatments.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either or the newer medication . Throughout the trial, you'll visit the study clinic for check-ups, blood tests, and assessments of your pain and overall well-being. The study involves about 1,116 participants across multiple hospitals, and your doctors will monitor you to make sure the medication is working and that you're not experiencing serious side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China